Liver transplantation in the management of porphyria
Open Access
- 22 February 2014
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 60 (3), 1082-1089
- https://doi.org/10.1002/hep.27086
Abstract
Porphyrias are a group of eight metabolic disorders, each resulting from a mutation that affects an enzyme of the heme biosynthetic pathway. Porphyrias are classified as hepatic or erythropoietic, depending upon the site where the gene defect is predominantly expressed. Clinical phenotypes are classified as follows: (1) acute porphyrias with neurovisceral symptoms: acute intermittent porphyria; delta amino‐levulinic acid hydratase deficiency porphyria; hereditary coproporphyria; and variegate porphyria and (2) cutaneous porphyrias with skin blistering and photosensitivity: porphyria cutanea tarda; congenital erythropoietic porphyria; hepatoerythropoietic porphyria and both erythropoietic protoporphyrias: autosomal dominant and X‐linked. Liver transplantation (LT) may be needed for recurrent and/or life‐threatening acute attack in acute intermittent porphyria or acute liver failure or end‐stage chronic liver disease in erythropoietic protoporphyria. LT in acute intermittent porphyria is curative. Erythropoietic protoporphyria patients needing LT should be considered for bone marrow transplantation to achieve cure. Conclusion: This article provides an overview of porphyria with diagnostic approaches and management strategies for specific porphyrias and recommendations for LT with indications, pretransplant evaluation, and posttransplant management. (Hepatology 2014;60:1082–1089)Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U54 DK083909)
This publication has 63 references indexed in Scilit:
- Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-upJournal of Clinical Pathology, 2012
- Protoporphyrin Retention in Hepatocytes and Kupffer Cells Prevents Sclerosing Cholangitis in Erythropoietic Protoporphyria Mouse ModelGastroenterology, 2011
- Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosisLiver Transplantation, 2011
- The role for BMT in erythropoietic protoporphyriaBone Marrow Transplantation, 2009
- C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron OverloadAmerican Journal of Human Genetics, 2008
- Sequential Liver and Bone Marrow Transplantation for Treatment of Erythropoietic ProtoporphyriaPEDIATRICS, 2006
- Liver transplantation for erythropoietic protoporphyria liver diseaseLiver Transplantation, 2005
- Recovery from a variegate porphyria by a liver transplantationLiver Transplantation, 2004
- Liver transplantation as a cure for acute intermittent porphyriaThe Lancet, 2004
- Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiencycclm, 1992